These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3904417)

  • 1. Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1).
    Greipp PR; Witzig TE; Gonchoroff NJ
    Am J Hematol; 1985 Nov; 20(3):289-92. PubMed ID: 3904417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma plasma cell kinetics: rapid and reliable evaluation using 5-bromo-2-deoxyuridine (BrdUrd) DNA incorporation detected by an anti-BrdUrd monoclonal antibody.
    Boccadoro M; Redoglio V; Gavarotti P; Pileri A
    Tumori; 1986 Apr; 72(2):135-7. PubMed ID: 3705185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.
    Greipp PR; Witzig TE; Gonchoroff NJ; Habermann TM; Katzmann JA; O'Fallon WM; Kyle RA
    Mayo Clin Proc; 1987 Nov; 62(11):969-77. PubMed ID: 3118117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.
    Witzig TE; Gonchoroff NJ; Greipp PR; Katzmann JA; Stenson MJ; Habermann TM; Colgan JP; Therneau TM; Banks PM
    Am J Clin Pathol; 1989 Mar; 91(3):298-301. PubMed ID: 2646907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
    Gunduz N
    Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation.
    Gonchoroff NJ; Greipp PR; Kyle RA; Katzmann JA
    Cytometry; 1985 Nov; 6(6):506-12. PubMed ID: 3905299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique.
    Lokhorst HM; Boom SE; Bast BJ; Ballieux RE
    Br J Haematol; 1986 Oct; 64(2):271-5. PubMed ID: 3535868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
    Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
    J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The bromodeoxyuridine index in multiple myeloma. I. Relation with selected laboratory indicators of the disease].
    Scudla V; Ordeltová M; Bacovský J; Spidlová A; Budíková M; Kubalová D; Zivná J
    Vnitr Lek; 1996 Jul; 42(7):458-62. PubMed ID: 8928421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
    Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
    Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
    Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R; Montecucco CM; Ciotti R; Girino M
    Cell Tissue Kinet; 1987 May; 20(3):311-8. PubMed ID: 3480077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67.
    Lokhorst HM; Boom SE; Terpstra W; Roholl P; Gerdes J; Bast BJ
    Br J Haematol; 1988 Aug; 69(4):477-81. PubMed ID: 3044442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma.
    Greipp PR; Katzmann JA; O'Fallon WM; Kyle RA
    Blood; 1988 Jul; 72(1):219-23. PubMed ID: 3291982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma.
    Karp JE; Burke PJ; Humphrey RL
    Blood; 1977 Jun; 49(6):925-34. PubMed ID: 861376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between plasma cell thymidine labelling index and serum beta-2-microglobulin in monoclonal gammopathies.
    Boccadoro M; Durie BG; Frutiger Y; Gavarotti P; Redoglia V; Massaia M; D'Alberto M; Marmont F; Gallamini A; Tribalto M
    Acta Haematol; 1987; 78(4):239-42. PubMed ID: 3122489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis.
    Joshua D; Petersen A; Brown R; Pope B; Snowdon L; Gibson J
    Br J Haematol; 1996 Jul; 94(1):76-81. PubMed ID: 8757512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies.
    Falini B; Canino S; Sacchi S; Ciani C; Martelli MF; Gerdes J; Stein H; Pileri S; Gobbi M; Fagioli M
    Br J Haematol; 1988 Jul; 69(3):311-20. PubMed ID: 3165668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmablastic transformation of multiple myeloma.
    Lee CK; Ma ES; Shek TW; Lam CC; Au WY; Wan TS; Chan LC
    Hum Pathol; 2003 Jul; 34(7):710-4. PubMed ID: 12874768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic Immunoglobulin Light Chain Revelation and Interphase Fluorescence In Situ Hybridization in Myeloma.
    Moore S; Suttle JM; Nicola M
    Methods Mol Biol; 2017; 1541():127-142. PubMed ID: 27910020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.